Quantum Dot gains two US NCI (National Cancer Institute) grants:
This article was originally published in Clinica
The US National Cancer Institute has awarded to Quantum Dot two grants to develop assays for the multiplexed analysis - ie performing many assays at one time - of breast cancer markers and for technology for detecting single target molecules on DNA microarrays. The new developments will use the company's Qdot tags, which are fluorescent semiconductor nanocrystals covalently attached to specific biological ligands. Hayward, California-based Quantum claims its tags are "much brighter, more photostable and easier to multiplex than conventional organic fluorescent dyes".